BISAGNI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 124
EU - Europa 94
AS - Asia 78
AF - Africa 2
SA - Sud America 1
Totale 299
Nazione #
US - Stati Uniti d'America 119
CN - Cina 53
SE - Svezia 27
IE - Irlanda 25
FI - Finlandia 17
SG - Singapore 17
IT - Italia 11
CA - Canada 5
DE - Germania 4
FR - Francia 4
TR - Turchia 4
CI - Costa d'Avorio 2
IN - India 2
IR - Iran 2
NL - Olanda 2
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GB - Regno Unito 1
UA - Ucraina 1
Totale 299
Città #
Chandler 27
Dublin 25
Santa Clara 15
Singapore 14
Dearborn 12
Beijing 9
Shanghai 9
New York 8
Ashburn 7
Nanjing 6
Boardman 4
Izmir 4
Jinan 4
Parma 4
Princeton 4
Toronto 4
Changsha 3
Hebei 3
Wilmington 3
Abidjan 2
Frankfurt am Main 2
Fremont 2
Hefei 2
Jiaxing 2
Kunming 2
Nanchang 2
Seattle 2
Tianjin 2
Ann Arbor 1
Bremen 1
Changchun 1
Dallas 1
Guangzhou 1
Haikou 1
Hangzhou 1
Helsinki 1
Leawood 1
Marseille 1
Norwalk 1
Ottawa 1
Pune 1
Rio Saliceto 1
Rockville 1
Shenyang 1
Sorø 1
São Paulo 1
Taizhou 1
Verona 1
Totale 203
Nome #
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 83
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 80
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 73
Higher expression of MIR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients 69
Totale 305
Categoria #
all - tutte 1.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 5 0 2 10 0 0
2020/20219 0 0 0 1 2 0 0 0 3 0 3 0
2021/202221 0 0 0 3 2 0 1 1 1 1 3 9
2022/202385 9 13 5 5 9 8 2 3 29 0 2 0
2023/202439 0 5 0 0 2 16 3 3 2 1 1 6
2024/202549 2 6 6 10 14 11 0 0 0 0 0 0
Totale 305